Journals / JAREM / 2012 / Cilt: 2 - Sayı: 3

Infravesical obstruction index in patients with benign prostatic hyperplasia is the best?

Benign Prostat büyümesi olan hastalarda infravezikal obstrüksiyon en iyi göstergesi nedir?

Journal
JAREM
Pages
109–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although IPSS is a subjective finding of infravesical obstruction, a higher score in patients with lower urinary tract symptoms is in parallel with the objective parameters such as Qmax and PVR.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study is to evaluate the correlation among the factors such as the International prostate symptom score (IPSS), uroflowmetry (Qmax), prostate volume and postvoiding residue (PVR) in predicting infravesical obstruction in patients with benign prostate hyperplasia.
📊
Key Findings & Data:Methods: The data of 134 patients referred to the urology outpatient clinic between January 2010 and December 2010 were retrospectively reviewed.
💡
Conclusion & Impact:Conclusion: Although IPSS is a subjective finding of infravesical obstruction, a higher score in patients with lower urinary tract symptoms is in parallel with the objective parameters such as Qmax and PVR.
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the study is to evaluate the correlation among the factors such as the International prostate symptom score (IPSS), uroflowmetry (Qmax), prostate volume and postvoiding residue (PVR) in predicting infravesical obstruction in patients with benign prostate hyperplasia. Methods: The data of 134 patients referred to the urology outpatient clinic between January 2010 and December 2010 were retrospectively reviewed. The patients were distributed in three groups according to IPSS values; 1st, lower IPSS group (n=35), 2nd, moderate IPSS group (n=67) and 3rd, higher IPSS group (n=32). IPSS, prostate volume, postvoiding residue (PVR), and maximum urine flow (Qmax) values were compared. Prostate volumes and PVR were evaluated with suprapubic ultrasound. The patients with comorbidities which may affect voiding function were excluded from the study. Results: The mean age and IPSS of study patients were 55.6 (43-88) and 13.5 (0-35) respectively. Mean prostate volume and PVR of the 3rd group were significantly higher compared to the 1st and 2nd groups. Conclusion: Although IPSS is a subjective finding of infravesical obstruction, a higher score in patients with lower urinary tract symptoms is in parallel with the objective parameters such as Qmax and PVR.

Özet

Amaç: Bu çalışmanın amacı, benign prostat hiperplazisi (BPH) olan hastalarda infravezikal obstrüksiyon derecesini tahmin etmekte kulanılan uluslararası prostat semptom skoru (IPSS) ile üroflovmetri, prostat volümü ve postmiksiyonel rezidüel idrar (PVR) miktarı arasındaki korelasyonu değerlendirmektir. Yöntemler: Üroloji polikliniğine Ocak 2010 ile Aralık 2010 tarihleri arasında başvuran işeme şikayeti ile muayene edilen 134 hasta retrospektif olarak incelendi. Hastalar IPSS değerlerine göre üç gruba ayrıldı; 1. Grup IPSS’i hafif olan hastalar (n=35 hasta), 2. Grup IPSS’i orta olan hastalar (n=67) ve 3. Grup IPSS’i olan hastalar (n=32). Hastaların IPSS ile prostat volümü, PVR ve üroflovmetri bulguları arasındaki ilişki karşılaştırıldı. Prostat hacimleri ile PVR suprapubik ultrasonografi ile değerlendirildi. İşemeyi etkileyebilecek üriner sistem rahatsızlıkları olan hastalar çalışmaya dahil edilmedi. Bulgular: Çalışmaya dahil edilen hastaların ortalama yaşı 55.6 (43-88) iken tüm grubun ortalama IPSS’si 13.5 (0-35) idi. Üçüncü gruptaki prostat hacimleri ve rezidüel idrar miktarları 1. Gruba ve 2. Gruba göre istatistiksel olarak anlamlı derecede daha fazla idi. Ortalama mesane duvar kalınlığı 2. Grup ve 3. Grup ile karşılaştırıldığında,1. Grupta anlamlı derecede daha düşük idi. Sonuç: Benign prostat hiperplazisi hastalarında IPSS öznel bir bulgu olsa da, alt üriner sistem yakınmaları daha yüksek olan hastalarda, nesnel olan üroflovmetri ve ultrasonografik parametrelerde de eşdeğer bir bozulma görülmektedir.

🔖

Cite This Article

ÇAKIROĞLU, B., SİNANOĞLU, O., HAZAR, A., BALCI, M. B. C., NUHOĞLU, B., AKSOY, S. H. (2012). Infravesical obstruction index in patients with benign prostatic hyperplasia is the best?. JAREM, Cilt: 2 - Sayı: 3, 109–112. https://ajindex.com/articles/214952

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Isaacs JT. Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacological intervention. Pros- tate 1990
  2. [CrossRef] 2. Garraway WM, Kirby RS. Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions.Urology 1994
  3. [CrossRef] 3. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom in- dex for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992
  4. AUA Practice Guidelines Committee. AUA guideline on mana- gement of benign prostatic hyperplasia (2003). Chapter 1: diag- nosis and treatment recommendations. J Urol 2003
  5. [CrossRef] 5. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisati- on of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl 1988
  6. Tanaka Y, Masumori N, Itoh N, Tsukamoto T, Furuya S, Ogura H. The prediction of bladder utlet obstruction with prostate volume, maximum flow rate, residual urine and the international prostate symptom score in patients with lower urinary tract symptoms. Hinyo- kika Kiyo 2001
  7. Park KK, Lee SH, Kim YJ, Choi YD, Mah SY. Association between urinary hesitancy symptoms and uroflowmetry measured urinary he- sitancy time in men with lower urinary tract symptoms. Neurourol Urodyn 2011
  8. [CrossRef] 8. Belal M, Abrams P. Noninvasivemethods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach. J Urol 2006
  9. [CrossRef] 9. Cornud F, Belin X, Piron D, Chretien Y, Flam T, Casanova JM, et al. Color Doppler-guided prostate biopsies in 591 patients with an ele- vated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997
  10. [CrossRef] 10. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993
  11. Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical pros- tatic protrusion with bladder outlet obstruction. BJU Int 2003
  12. [CrossRef] 12. Oelke M, Höfner K, Jonas U, de la Rosette JJ, Ubbink DT, Wijkstra H. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvo- id residual uri